EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Exosomes as a Source of Biomarkers for Gastrointestinal Cancers

Jingjing Yu iD, Arsha Ostowari iD, Amber Gonda, Kiarash Mashayekhi, Farshid Dayyani iD, Christopher C W Hughes, Maheswari Senthil iD

Cancers · 16.02.2023 · 15 (4) · 1263

DOI: 10.3390/cancers15041263 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 16.02.2023. Verfasst von Jingjing Yu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of California, Irvine Medical Center, Orange, CA 92868, USA. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Exosomes are small, lipid-bilayer bound extracellular vesicles of 40–160 nanometers in size that carry important information for intercellular communication. Exosomes are produced more by tumor cells than normal cells and carry tumor-specific content, such as DNA, RNA, and proteins, which have been implicated in tumorigenesis, tumor progression, and treatment response. Due to the critical role of exosomes in cancer development and progression, they can be exploited to develop specific biomarkers and therapeutic targets. Since exosomes are present in various biofluids, such as blood, saliva, urine, and peritoneal fluid, they are ideally suited to be developed as liquid biopsy tools for early diagnosis, molecular profiling, disease surveillance, and treatment response monitoring. In the past decade, numerous studies have been published about the functional significance of exosomes in a wide variety of cancers, with a particular focus on exosome-derived RNAs and proteins as biomarkers. In this review, utilizing human studies on exosomes, we highlight their potential as diagnostic, prognostic, and predictive biomarkers in gastrointestinal cancers.

Schlagwörter

Stichwörter der Autor:innen

biomarkerexosomesgastrointestinal cancersliquid biopsy

Autor:innen und Institutionen

  • Department of Surgery, University of California, Irvine Medical Center, Orange, CA 92868, USA.
  • Division of Hematology/Oncology, Department of Medicine, University of California, Irvine Medical Center, Orange, CA 92868, USA.
  • Department of Molecular Biology & Biochemistry and Department of Biomedical Engineering, University of California, Irvine, CA 92697, USA.

ORCID-Profile: Jingjing Yu, Arsha Ostowari, Farshid Dayyani, Maheswari Senthil

Förderung

  • NCI NIH HHS

Zitieren

APA

Yu, J., Ostowari, A., Gonda, A., Mashayekhi, K., Dayyani, F., Hughes, C. C. W., & Senthil, M. (2023). Exosomes as a Source of Biomarkers for Gastrointestinal Cancers. Cancers, 15(4), 1263. https://doi.org/10.3390/cancers15041263

Vancouver

Yu J, Ostowari A, Gonda A, Mashayekhi K, Dayyani F, Hughes CCW, et al. Exosomes as a Source of Biomarkers for Gastrointestinal Cancers. Cancers. 2023;15(4):1263. doi:10.3390/cancers15041263

BibTeX
@article{Yu2023,
  author = {Yu, Jingjing and Ostowari, Arsha and Gonda, Amber and Mashayekhi, Kiarash and Dayyani, Farshid and Hughes, Christopher C W and Senthil, Maheswari},
  title = {Exosomes as a Source of Biomarkers for Gastrointestinal Cancers},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {4},
  pages = {1263},
  doi = {10.3390/cancers15041263}
}
Kostenlos starten →